Device evidence, reimagined
Research-ready data with unmatched precision and traceability
Thank you for your interest!
Device-level data from EHRs, claims, and chargemaster
Breadth and depth with full traceability
Traditional, standalone data sources—claims, chargemaster, and registries—were never built for lifecycle-wide evidence. They provide fragments of the picture but, alone, cannot deliver the precision, speed, or representativeness regulators and payers now expect.
Truveta’s governing health systems contribute de-identified EHR and chargemaster data directly, delivering unmatched clinical depth with full provenance back to source. Linked claims extend that insight, providing cost and utilization data to power robust economic analyses with clinical context.
patients
unique devices
years longitudinal data
devices + claims
devices + imaging
devices + clinical notes
Purpose-built for device evidence
Get the details needed to study utilization, safety, effectiveness, and cost with confidence.Â

Device-level granularity

Device-level granularity

Admission–Discharge–Transfer (ADT) data

Admission–Discharge–Transfer (ADT) data

Procedure log data

Procedure log data

Linked chargemaster

Linked chargemaster

Clinical notes

Clinical notes

Imaging at scale

Imaging at scale
Evidence across the lifecycle, in any therapeutic area
Across cardiovascular, orthopedics, neurology, and more, Truveta accelerates adoption and reduces risk across the lifecycle.

De-risk trial design with modeled eligibility, comparator arms, and site feasibility.

Monitor safety signals in real time across care settings.

Generate evidence for regulatory submissions with traceable, auditable source data.

Demonstrate value to payers by linking utilization, outcomes, and costs.

Expand total addressable market by uncovering disparities in access and adoption.